We measure ourselves by the impact we have on lives and the return we deliver to our investors
VENTURE CAPITAL
OF INNOVATIVE MEDICINE
SEASONED
INVESTMENT TEAM
6
in total
5
PhDs
3
MDs
50%
female/male
DRIVING
PORTFOLIO PROGRESS
20
investments in total
10
clinical programs
2
registered products
4
deals/collaboration with Pharma
ACTIVE
OWNERSHIP
11
company creation
12
board seats
2
chairpersonships
1
CEO role
STELLAR
SYNDICATION
36
different international syndication partners including top tier from Nordics, Europe and US
Eir Ventures strive for Nordic innovation to drive global health forward to improve millions of lives and deliver high return fund after fund.
Our investment triad applies to every company in our portfolio: Transformative potential, Excellence in execution and Scalability
Our experienced team are curious, tenacious and engaged. We understand how to translate rapidly evolving innovations into business opportunities and patient benefits